The KEGG pathway analysis showed that the risk DEGs were mainly enriched in some cancer or immune-related pathways, including “complement and coagulation cascades,” “p53 signaling pathway”, “transcriptional misregulation in cancer,” and so on (Figure 4C). This evidence concerns the gene TP53 and cancer.